Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09EGZ
|
||||
Former ID |
DAP000165
|
||||
Drug Name |
Chloroquine
|
||||
Synonyms |
Amokin; Aralen; Arechin; Arechine; Arequin; Arolen; Arthrochin; Artrichin; Avlochlor; Avloclor; Bemaco; Bemaphate; Bemasulph; Benaquin; Bipiquin; Capquin; Chemochin; Chingamin; Chloraquine; Chlorochin; Chlorochine; Chlorochinum; Chloroin; Chloroquin; Chloroquina; Chloroquinium; Chloroquinum; Chlorquin; Cidanchin; Clorochina; Cloroquina; Cocartrit; Delagil; Dichinalex; Elestol; Gontochin; Heliopar; Imagon; Iroquine; Khingamin; Klorokin; Lapaquin; Malaquin; Malaren; Malarex; Mesylith; Miniquine; Neochin; Nivachine; Pfizerquine; Quinachlor; Quinagamin; Quinagamine; Quinercyl; Quingamine; Quinilon; Quinoscan; Resochen; Resochin; Resoquina; Resoquine; Reumachlor; Reumaquin; Rivoquine; Ronaquine; Roquine; Sanoquin; Silbesan;Siragan; Solprina; Sopaquin; Tanakan; Tanakene; Tresochin; Trochin; Aralen HCl; Chloroquine phosphate; Clorochina [DCIT]; Gontochin phosphate; Nivaquine B; Ipsen 225; RP 3377; SN 6718; ST 21; W 7618;WIN 244; Chloroquine (VAN); Chloroquine Bis-Phosphoric Acid; Chloroquine FNA (TN); Chloroquinum [INN-Latin]; Cloroquina [INN-Spanish]; Dawaquin (TN); RP-3377; Resochin (TN); SN-7618; ST 21 (pharmaceutical); CU-01000012392-2; Chloroquine (USP/INN); Chloroquine [USAN:INN:BAN]; Ro 01-6014/N2; Malaquin (*Diphosphate*); {4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine; N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine; N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine; (+)-Chloroquine; (-)-Chloroquine; (R)-(-)-Chloroquine; 3377 RP opalate; 7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline; 7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antimalarials
|
||||
Company |
Medreich Sterilab Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H26ClN3
|
||||
InChI |
InChI=1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21)
|
||||
InChIKey |
WHTVZRBIWZFKQO-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 54-05-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9827, 447935, 596572, 5050990, 7849425, 7978921, 8151759, 10526125, 11335579, 11360818, 11363006, 11365568, 11368130, 11371321, 11373917, 11376292, 11404351, 11405289, 11461790, 11466576, 11467696, 11483910, 11486252, 11487943, 11490157, 11492094, 11493946, 11528736, 14776983, 26675665, 29221876, 46506925, 47217037, 47291356, 47440521, 47440522, 47885638, 48035387, 48110720, 48185227, 48259487, 49635547, 49681217, 49698849, 49846799, 50111008, 53787949, 53788124, 56310729, 57321414
|
||||
ChEBI ID |
ChEBI:3638
|
||||
SuperDrug ATC ID |
P01BA01
|
||||
SuperDrug CAS ID |
cas=000054057
|
||||
Drug Resistance Mutation (DRM) | |||||
DRM | DRM Info | ||||
Target and Pathway | |||||
Target(s) | Duffy antigen chemokine receptor | Target Info | Modulator | [556264] | |
References | |||||
Ref 536135 | Opportunities and challenges in antiparasitic drug discovery. Nat Rev Drug Discov. 2005 Sep;4(9):727-40. | ||||
Ref 540925 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5535). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.